Gregorich, Mariella
Heinzel, Andreas
Kammer, Michael
Meiselbach, Heike
Böger, Carsten
Eckardt, Kai-Uwe
Mayer, Gert
Heinze, Georg
Oberbauer, Rainer http://orcid.org/0000-0001-7544-6275
Funding for this research was provided by:
h2020 european research council (115974)
Article History
Received: 26 July 2021
Accepted: 22 October 2021
First Online: 18 November 2021
Declarations
:
: The PROVALID study protocol was approved in each participating country by the responsible local Institutional Review Board (IRB). Signing an informed consent was a prerequisite for study participation in all countries. The GCKD study protocol was approved by local institutional review boards at each participating academic institution, and the data protection concept was reviewed by the data protection officer of the State of Hessen. The DIACORE study protocol, the data protection strategy, and the study procedures have been approved by the Ethics Committees of participating institutions and are in accordance with the Declaration of Helsinki. Patients participate in DIACORE only after providing informed written consent.
: Not applicable.
: The authors declare that they have no competing interests.